ClinicalTrials.gg

Program

Insulin, Regular, Human

Also written as “Technosphere Insulin”, “inhaled human insulin” and “Human Insulin Inhalation Powder”.

Its studies are mostly in Diabetes Mellitus, Type 2 · Diabetes Mellitus, Type 1 · Diabetes Mellitus · Asthma · Diabetes, Gestational, led by 13 companies.

Furthest: phase 4, since Apr 16, 202179 company-led studies, 2 open or runningNext primary completion: Mar 2027 (phase 2)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Mannkind261 open or runningphase 4since Apr 16, 2021Mar 27, 2006Mar 2027phase 2 · NCT07224321
Novo Nordisk190 open or runningphase 4since Aug 10, 2006Jul 17, 2003none ahead
Eli Lilly100 open or runningphase 4since Jan 22, 2013Aug 4, 2005none ahead
Biodel50 open or runningphase 3since Oct 5, 2007Oct 5, 2007none ahead
Pfizer40 open or runningphase 3since Feb 2, 2006Feb 2, 2006none ahead
Dance Biopharm30 open or runningphase 2since Mar 9, 2016Mar 9, 2016none ahead
Halozyme Therapeutics30 open or runningphase 2since Oct 15, 2008Jun 24, 2008none ahead
Sanofi30 open or runningphase 4since Jun 26, 2012Sep 2, 2010none ahead
Transdermal Delivery Solutions21 open or runningphase 3since Dec 1, 2021Apr 21, 2021Oct 15, 2027phase 3 · NCT05159453
diabetes-and-glandular-disease-clinic10 open or runningphase 4since Oct 9, 2019Oct 9, 2019none ahead
ikfe-cro-gmbh10 open or runningphase 4since Dec 5, 2011Dec 5, 2011none ahead
informed-data-systems-inc10 open or runningphase 4since Oct 10, 2017Oct 10, 2017none ahead
The United Laboratories International10 open or runningphase 1since May 5, 2026May 5, 2026none ahead

Also a collaborator on its studies: langford-research-institute-inc, Insulet, DexCom, Profil Institut für Stoffwechselforschung, Alkermes, wcct-global and Nektar Therapeutics.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

Before these, 46 studies since Dec 11, 2006.

  1. Sep 23, 2015Phase 3 study in Diabetes Mellitus, Type 2Eli Lilly · NCT02561078 · 420 enrolled · United States, Puerto Rico
  2. Mar 9, 2016Dance Biopharm's first study: phase 2 study in Diabetes Mellitus, Type 2New to Dance BiopharmDance Biopharm · NCT02716610 · 24 enrolled
  3. Oct 2, 2017Phase 2 study in AsthmaDance Biopharm · NCT03307512 · 40 enrolled · United States
  4. Oct 10, 2017informed-data-systems-inc's first study: phase 4 study in Diabetes Mellitus, Type 2New to informed-data-systems-incinformed-data-systems-inc · NCT03313960 · 400 enrolled · United States
  5. Feb 25, 2019Phase 2 study in Diabetes Mellitus, Type 2Dance Biopharm · NCT04100473 · 24 enrolled · Germany
  6. Oct 9, 2019diabetes-and-glandular-disease-clinic's first study: phase 4 study in Type 2 Diabetes Treated With InsulinNew to diabetes-and-glandular-disease-clinicdiabetes-and-glandular-disease-clinic · NCT04125082 · 29 enrolled · United States
  7. Apr 16, 2021Phase 4 study in Diabetes Mellitus, Type 1Mannkind · NCT04849845 · 20 enrolled · United States
  8. Apr 21, 2021Transdermal Delivery Solutions's first study: early phase 1 study in Pharmacodynamic Response to Small Doses of InsulinNew to Transdermal Delivery SolutionsTransdermal Delivery Solutions · NCT04857320 · 7 enrolled · United States
  9. Jun 22, 2021Phase 3 study in Diabetes Mellitus, Type 1Mannkind · NCT04974528 · 319 enrolled · United States
  10. Dec 1, 2021Phase 3 study in Glucose, High BloodTransdermal Delivery Solutions · NCT05159453 · 30 planned · United States
  11. Feb 7, 2022Phase 4 study in Diabetes Mellitus, Type 1Mannkind · NCT05243628 · 33 enrolled · United States
  12. Jun 2, 2023Phase 4 study in Diabetes Mellitus, Type 1Mannkind · NCT05904743 · 141 enrolled · United States
  13. Oct 31, 2025Phase 2 study in Diabetes Mellitus, Type 1Mannkind · NCT07224321 · 100 planned · United States
  14. May 5, 2026The United Laboratories International's first study: phase 1 study in Pharmacokinetics and PharmacodynamicsNew to The United Laboratories InternationalThe United Laboratories International · NCT07608692 · 32 enrolled · China

Ahead

  1. Mar 2027Primary completion: phase 2 study in Diabetes Mellitus, Type 1Mannkind · NCT07224321
  2. Oct 15, 2027Primary completion: phase 3 study in Glucose, High BloodTransdermal Delivery Solutions · NCT05159453

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

The newest 60 of 79 led by companies developing it. Each opens its study page. Every study on its drug page →

StudyPhaseStatusLed byPrimary completionSize
NCT07608692Pharmacokinetics and Pharmacodynamics · China1CompletedThe United Laboratories InternationalNov 25, 202532
NCT07224321Diabetes Mellitus, Type 1 · United States2RecruitingMannkindMar 2027100
NCT05904743Diabetes Mellitus, Type 1 · United States4CompletedMannkindMar 26, 2024141
NCT05243628Diabetes Mellitus, Type 1 · United States4CompletedMannkindOct 17, 202233
NCT05159453Glucose, High Blood · United States3Not yet recruitingTransdermal Delivery SolutionsOct 15, 202730
NCT04974528Diabetes Mellitus, Type 1 · United States3CompletedMannkindOct 3, 2024319
NCT04857320Pharmacodynamic Response to Small Doses of Insulin · United StatesEarly 1CompletedTransdermal Delivery SolutionsNov 15, 20217
NCT04849845Diabetes Mellitus, Type 1 · United States4CompletedMannkindMay 28, 202120
NCT04125082Type 2 Diabetes Treated With Insulin · United States4UNKNOWNdiabetes-and-glandular-disease-clinicMar 15, 202029
NCT04100473Diabetes Mellitus, Type 2 · Germany2CompletedDance BiopharmAug 11, 201824
NCT03313960Diabetes Mellitus, Type 2 · United States4UNKNOWNinformed-data-systems-incSep 30, 2018400
NCT03307512Asthma · United States2TerminatedDance BiopharmJul 30, 201940
NCT02716610Diabetes Mellitus, Type 22CompletedDance BiopharmJan 201424
NCT02561078Diabetes Mellitus, Type 2 · United States, Puerto Rico3CompletedEli LillyMay 9, 2017420
NCT02527265Diabetes Mellitus, Type 1 · United States2CompletedMannkindMar 17, 202030
NCT02485327Diabetes Mellitus, Type 1 · Germany1CompletedMannkindNov 201522
NCT01774968Diabetes Mellitus, Type 2 · United States, Puerto Rico4CompletedEli LillyMay 2014325
NCT01630369Diabetes Mellitus, Type 2 · Ukraine4CompletedSanofiMay 2013552
NCT01544881Diabetes Mellitus, Type 1 · United States1CompletedMannkindSep 201217
NCT01500850Diabetes Mellitus, Type 2 · Germany4UNKNOWNikfe-cro-gmbhOct 201260
NCT01451398Diabetes Mellitus, Type 2 · United States, Brazil, Russian Federation and more3CompletedMannkindJun 2013353
NCT01448070Diabetes Mellitus · United Kingdom1CompletedNovo NordiskDec 20, 200228
NCT01365117Healthy Volunteers · United States1CompletedMannkindFeb 201150
NCT01353469Diabetes Mellitus, Type 2 · China3CompletedSanofiNov 2012485
NCT01269606Diabetes Mellitus · Japan1CompletedNovo NordiskMar 201113
NCT01194882Diabetes Mellitus, Type 1 · Belgium, France, Netherlands and more3CompletedSanofiFeb 1, 2018479
NCT01000922Diabetes Mellitus · United States2CompletedBiodelJan 200824
NCT00934414Diabetes Mellitus, Type 2 · United States2CompletedMannkindAug 200624
NCT00916357Diabetes Mellitus, Type 2 · United States2CompletedHalozyme TherapeuticsNov 200923
NCT00875459Diabetes Mellitus3CompletedBiodelFeb 2010233
NCT00875108Diabetes Mellitus3CompletedBiodelJan 2010116
NCT00774800Diabetes Mellitus, Type 1 · United States2CompletedHalozyme TherapeuticsMar 200922
NCT00725036Diabetes Mellitus · Australia3CompletedNovo NordiskDec 14, 2004305
NCT00705536Diabetes Mellitus · United States1CompletedHalozyme TherapeuticsFeb 200826
NCT00700622Diabetes Mellitus, Type 1 · United States, Brazil3TerminatedMannkindNov 2009130
NCT00676819Diabetes Mellitus · Germany4CompletedNovo NordiskJul 19, 200219
NCT00662857Diabetes Mellitus, Type 1 · United States2CompletedMannkindNov 200829
NCT00642616Diabetes Mellitus, Type 1 · United States, Russian Federation, Ukraine3TerminatedMannkindNov 201434
NCT00617565Diabetes Mellitus · China3CompletedNovo NordiskNov 26, 2003219
NCT00570687Diabetes Mellitus, Type 2 · Germany2CompletedMannkindJan 200930
NCT00569400Diabetes Mellitus · Australia, Hong Kong, Malaysia and more3CompletedNovo NordiskJan 19, 2004241
NCT00567775Diabetes Mellitus · Denmark2CompletedNovo NordiskNov 20, 200227
NCT00542633Diabetes Mellitus, Type 23CompletedBiodelAug 2008472
NCT00542724Diabetes Mellitus, Type 13CompletedBiodelJul 2008462
NCT00539890Diabetes Mellitus, Type 2 · Russian Federation3CompletedMannkind0
NCT00539396Diabetes Mellitus, Type 12CompletedMannkind110
NCT00523042Diabetes Mellitus · United States, Australia, Former Serbia and Montenegro and more3TerminatedNovo NordiskFeb 28, 200810
NCT00511979Healthy1CompletedMannkindFeb 200012
NCT00511732Diabetes Mellitus, Type 22CompletedMannkindAug 2005227
NCT00511719Diabetes Mellitus, Type 22CompletedMannkindApr 200413
NCT00511602Diabetes Mellitus, Type 22CompletedMannkindNov 2004123
NCT00490854Diabetes Mellitus, Type 2 · Japan3CompletedEli LillyMay 2008129
NCT00476437Diabetes Mellitus · Japan3CompletedNovo NordiskNov 200781
NCT00472953Diabetes Mellitus · Argentina, India, Romania and more3TerminatedNovo NordiskMar 5, 200838
NCT00469586Diabetes Mellitus · Argentina, Austria, Belgium and more3TerminatedNovo NordiskApr 24, 2008174
NCT00427154Diabetes Mellitus · United States3TerminatedNovo NordiskMar 11, 2008227
NCT00424437Diabetes Mellitus, Type 1 · United States, Canada3CompletedPfizer320
NCT00424333Diabetes Mellitus, Type 1 · United States, Canada3CompletedPfizer320
NCT00419718Diabetes Mellitus · Austria1CompletedNovo NordiskNov 200523
NCT00410033Diabetes Mellitus · Sweden–CompletedNovo NordiskMay 200674

How it is read

Names in the registry

  • “Technosphere Insulin”, 13 entries
  • “inhaled human insulin”, 12 entries
  • “Human Insulin Inhalation Powder”, 7 entries
  • “human insulin”, 7 entries
  • “Technosphere® Insulin Inhalation Powder”, 5 entries

Codes read as this program: INH69, INH139, INH208, HR1799.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.